IRONWOOD PHARMACEUTICALS INC (IRWD)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 85,239 | 41,143 | 91,592 | 94,396 |
| Selling, general and administrative | 16,795 | 24,260 | 36,113 | 36,964 |
| Research and development | 23,373 | 27,432 | 29,827 | 30,388 |
| Restructuring, net | -250 | 18,559 | 16 | 2,067 |
| Total costs and expenses | 39,918 | 70,251 | 65,956 | 69,419 |
| Income from operations | 45,321 | -29,108 | 25,636 | 24,977 |
| Other | 39 | 37 | - | - |
| Interest and investment income | 818 | 869 | 1,152 | 1,369 |
| Interest expense and other financing costs | 8,356 | 8,070 | 9,419 | 7,470 |
| Other income (expense), net | -7,499 | -7,164 | -8,267 | -6,101 |
| Income before income taxes | 37,822 | -36,272 | 17,369 | 18,876 |
| Income tax expense | 14,223 | 1,114 | 13,723 | 19,736 |
| Net income (loss), including portion attributable to noncontrolling interest | - | - | 3,646 | -860 |
| Net income (loss) | 23,599 | -37,386 | 3,646 | -860 |
| Earnings per share, basic | 0.15 | -0.23 | 0.02 | -0.01 |
| Earnings per share, diluted | 0.14 | -0.23 | 0.02 | -0.01 |
| Weighted average number of shares outstanding, basic | 161,723,000 | 160,974,000 | 159,706,000 | 159,014,000 |
| Weighted average number of shares outstanding, diluted | 176,837,000 | 160,974,000 | 160,232,000 | 159,014,000 |